EUVIMEDEUVIMED entdecken
Crossref

Proteolytic Colonic Microbiota Is Associated with Increased Clinical and Endoscopic Disease Activity in Ulcerative Colitis Running head : Microbiota and disease activity in ulcerative colitis

Jessica Kwenandar, A.M. Luthfi Parewangi, Femi Syahriani, Syakib Bakri, Dimas Bayu, Arifin Seweng

International Journal of Drug Delivery Technology · 20.06.2026 · 16 (57s)

DOI: 10.25258/ijddt.16.57s.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 20.06.2026. Verfasst von Jessica Kwenandar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory bowel disease with an increasing burden in Asia. Although gut microbiota alterations have been widely reported in UC, evidence linking microbiota patterns with both clinical and endoscopic disease activity remains limited, particularly in Indonesian populations. This study aimed to evaluate the association between colonic microbiota patterns and clinical and endoscopic disease activity in patients with UC. This cross-sectional study was conducted at a tertiary referral hospital in Makassar, Indonesia. Adult patients with UC undergoing lower gastrointestinal endoscopy were consecutively recruited. Colonic samples were collected during endoscopy and analyzed using 16S rRNA sequencing targeting the V3–V5 region. Microbiota were classified as saccharolytic (Firmicutes, Bacteroidetes) or proteolytic (Proteobacteria, Actinobacteria, Euryarchaeota). Disease activity was assessed using the Mayo Clinical Score (MCS) and the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). A total of 53 patients were included. Proteobacteria was the dominant phylum in 62.3% of patients, and 66.0% exhibited a proteolytic microbiota pattern. Moderate–severe disease activity was observed in 37.7% of patients based on MCS and 32.1% based on UCEIS. A proteolytic microbiota pattern was significantly associated with moderate–severe clinical disease activity (OR 8.47; 95% CI 1.69–42.48; p=0.009) and moderate–severe endoscopic disease activity (OR 6.00; 95% CI 1.19–30.17; p=0.030). A proteolytic colonic microbiota pattern was significantly associated with increased clinical and endoscopic disease activity in UC, suggesting that microbiota composition may reflect inflammatory burden. Further longitudinal studies are required to confirm these associations..

Zitieren

APA

Kwenandar, J., Parewangi, A. L., Syahriani, F., Bakri, S., Bayu, D., & Seweng, A. (2026). Proteolytic Colonic Microbiota Is Associated with Increased Clinical and Endoscopic Disease Activity in Ulcerative Colitis Running head : Microbiota and disease activity in ulcerative colitis. International Journal of Drug Delivery Technology, 16(57s). https://doi.org/10.25258/ijddt.16.57s.9

Vancouver

Kwenandar J, Parewangi AL, Syahriani F, Bakri S, Bayu D, Seweng A. Proteolytic Colonic Microbiota Is Associated with Increased Clinical and Endoscopic Disease Activity in Ulcerative Colitis Running head : Microbiota and disease activity in ulcerative colitis. International Journal of Drug Delivery Technology. 2026;16(57s). doi:10.25258/ijddt.16.57s.9

BibTeX
@article{Kwenandar2026,
  author = {Kwenandar, Jessica and Parewangi, A.M. Luthfi and Syahriani, Femi and Bakri, Syakib and Bayu, Dimas and Seweng, Arifin},
  title = {Proteolytic Colonic Microbiota Is Associated with Increased Clinical and Endoscopic Disease Activity in Ulcerative Colitis Running head : Microbiota and disease activity in ulcerative colitis},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {57s},
  doi = {10.25258/ijddt.16.57s.9}
}
Kostenlos starten →